- ------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
----------------------------------
WASHINGTON, D.C. 20549
-----------------------
-------------
SCHEDULE 13D
------------
UNDER THE SECURITIES ACT OF 1934
--------------------------------
BIOMERICA, INC.
---------------
(Name of Issuer)
----------------
$.08 Par Value Common Stock
---------------------------
(Title of Class of Securities)
09061H 30 7
-----------
(CUSIP Number)
Janet Moore, 1533 Monrovia Avenue, Newport Beach, California 92663
------------------------------------------------------------------
(Name, Address, Telephone Number of Person Authorized to Receive Notice and
Communications)
July 2, 1998
----------------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(4)(i)(A) or (B), check the following box [ ].
1. Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above
Persons
Janet Moore
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
3. SEC Use Only
4. Source of Funds (See Instructions)
<PAGE>
Janet Moore OO
5. Check if Disclosure of Legal Proceedings in Required Pursuant to Items 2(d)
or 2(e)
-----------------------------------------------------------------------
6. Citizenship or Place of Organization
Janet Moore United States
7. Number of Shares Beneficially Owned by Each Reporting Person With Sole
Voting Power
Janet Moore 465,670
8. Shared Voting Power
Janet Moore 0
9. Sole Dispositive Power
Janet Moore 465,670
10. Shared Dispositive Power
Janet Moore 0
11. Aggregate Amount Beneficially Owned by Each Reporting Person
See Item 9, above.
12 Check if the Aggregate Amount in Row 11 Excludes Certain Shares (See
Instructions)
13. Percent of Class Represented by Amount in Row 11
Janet Moore 11.7%
14. Type of Reporting Person (See Instructions)
Janet Moore IN
Item 1. Security and Issuer.
-------------------
<PAGE>
The statement relates to the $.08 par value common stock of Biomerica,
Inc. (the "Registrant"), a Delaware corporation.
Item 2. Identity and Background.
-----------------------
Janet Moore
1533 Monrovia Avenue
Newport Beach, California 92663
The principal occupation of Janet Moore is controller of Biomerica,
Inc. ("BMRA"), the Registrant.
Item 3. Source and Amount of Funds or Other Consideration.
-------------------------------------------------
Janet Moore OO*
* Shares acquired through distribution of the estate of Joseph Irani.
Item 4. Purpose of Transaction.
----------------------
On April 28, 1997, Mr. Joseph Irani, Chairman of the Board, President
and Chief Financial Officer of Biomerica died of natural causes. Pursuant to
the terms of his will, 387,010 shares of common stock were distributed to Janet
Moore, his wife and Director and controller of Biomerica, giving Ms. Moore
465,670 directly owned shares of Biomerica.
Item 5. Interest in Securities of the Issuer.
------------------------------------
Janet Moore 11.50%
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect
---------------------------------------------------------------------
to Securities of the Issuer.
---------------------------
See Item 4, above.
Item 7. Material to be Filed as Exhibits.
--------------------------------
None
<PAGE>
After reasonable inquiry and to the best or our knowledge and belief, we certify
that the information set forth in this statement is true, complete and correct.
Dated: September 3, 1998 /s/ Janet Moore
----------------
